The changes include recommendations for first line immunotherapy in patients with high PD-L1 expression, and clarification on use of targeted therapies.
Using data from TCGA and the HPA, they looked at the prognostic role of each protein-coding gene in 7,932 tumor samples spanning 17 different tumor types.
The company plans to use proceeds to further invest in its development of molecular testing and other strategies in the preventive medicine space.
A Complete Genomics-led team isolated and sequenced the genomes of 34 circulating tumor cells from a woman with metastatic breast cancer.
The company, which also said it is short on funds, may have to pay $18.3 million to Hudson Bay Master Fund if forebearance is not granted for the default.
Under the terms of the deal, Fluidigm has the right to commercialize the CFTR sample prep assay for research use on its Juno automated microfluidic system.
The firm is looking for outside partners to tackle test commercialization as it begins to bring its second-generation colorectal cancer assay to market.
The agricultural company said it will use the licensed technology to develop improved and sustainable crops.
US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.
In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.
The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.
In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.